DMC1 Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">dmc1</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>DMC1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>DNA Meiotic Recombinase 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>22q13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>11144</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000101339</td>
</tr>
<tr>
<td class="label">Protein Size</td>
<td>340 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~37 kDa</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Overview
DMC1 is a human gene. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration. [@yang2005]
DMC1 (DNA Meiotic Recombinase 1) encodes a key recombinase enzyme essential for homologous recombination during meiosis and the repair of DNA double-strand breaks (DSBs). The DMC1 protein belongs to the Rad51 recombinase family and plays a critical role in maintaining genomic integrity through accurate DNA strand invasion and exchange during recombination [1](https://pubmed.ncbi.nlm.nih.gov/1330584/). While primarily studied in the context of meiosis, DMC1's involvement in DNA repair pathways has significant implications for understanding neurodegeneration, as defective DNA repair is a hallmark of multiple neurodegenerative disorders [2](https://pubmed.ncbi.nlm.nih.gov/25448606/). [@cejka2010]
Gene Overview
The DMC1 gene spans approximately 12 kb and consists of 13 exons. It encodes a recombinase protein that catalyzes the exchange of DNA strands during homologous recombination, a process essential for the repair of double-strand breaks and the maintenance of genomic stability [1](https://pubmed.ncbi.nlm.nih.gov/1330584/). The protein is expressed predominantly in testis but is also expressed at lower levels in other tissues including brain, where it participates in DNA repair [3](https://pubmed.ncbi.nlm.nih.gov/11242053/). [@hirai2015]
Molecular Function
Homologous Recombination
DMC1 mediates the central reaction of homologous recombination: the invasion of a single-stranded DNA (ssDNA) molecule into a homologous double-stranded DNA (dsDNA) molecule to form a joint molecule (JM) intermediate [1](https://pubmed.ncbi.nlm.nih.gov/1330584/). This process involves: [@parker2005]
ssDNA binding: DMC1 assembles on ssDNA to form a nucleoprotein filament
Homology search: The filament searches for homologous sequences in the genome
Strand invasion: DMC1 promotes the invasion of ssDNA into dsDNA, forming a D-loop
DNA synthesis: DNA polymerase extends the invading 3' end using the homologous template
Branch migration: The holiday junction is resolved through branch migration
Holliday junction resolution: Final resolution produces crossover or non-crossover productsThe homologous recombination pathway is critical for maintaining genomic stability, particularly in proliferating cells. However, accumulating evidence suggests that DNA repair pathways are also important in post-mitotic neurons, which face significant DNA damage challenges throughout the lifespan [4](https://pubmed.ncbi.nlm.nih.gov/12697932/). [@mandonpepin2017]
ATP Hydrolysis and Filament Dynamics
Like other RecA-family recombinases, DMC1 exhibits ATPase activity that drives the conformational changes necessary for DNA strand exchange [5](https://pubmed.ncbi.nlm.nih.gov/11867556/). ATP binding induces filament formation, while ATP hydrolysis provides the energy for strand invasion and exchange. The ATPase activity is regulated by accessory proteins including RAD51, BRCA2, and MEIOBSPERT [6](https://pubmed.ncbi.nlm.nih.gov/11867557/). [@kumari2020]
The formation and stability of the DMC1-ssDNA filament is a carefully regulated process: [@sanchezbadillo2017]
- Nucleation: DMC1 initially binds to ssDNA at specific sites
- Filament extension: Additional DMC1 monomers add to the filament
- ATP-dependent stabilization: ATP binding stabilizes the filament
- ATP hydrolysis: Provides energy for strand exchange
- Filament disassembly: Mediated by ATP hydrolysis and accessory proteins
Recent cryo-EM structures have revealed the detailed mechanism of DMC1-ssDNA filament formation and strand invasion [7](https://pubmed.ncbi.nlm.nih.gov/32025013/). [@qiu2015]
Interaction Partners
DMC1 interacts with several key proteins in the DNA repair pathway: [@takaku2018]
- RAD51: The primary recombinase for mitotic DNA repair; DMC1 and RAD51 function cooperatively [1](https://pubmed.ncbi.nlm.nih.gov/1330584/)
- BRCA2: Facilitates DMC1 loading onto ssDNA through interaction with RAD51 [6](https://pubmed.ncbi.nlm.nih.gov/11867557/)
- MEIOBSPERT: Meiosis-specific protein essential for DMC1 function in meiosis [8](https://pubmed.ncbi.nlm.nih.gov/14627623/)
- HOP2: Stabilizes DMC1-ssDNA filaments and promotes strand invasion [9](https://pubmed.ncbi.nlm.nih.gov/15812426/)
- Mnd1: Forms a complex with HOP2 to stimulate DMC1 activity [10](https://pubmed.ncbi.nlm.nih.gov/17482518/)
- XRCC3: Promotes DMC1 filament stability and recombination efficiency [11](https://pubmed.ncbi.nlm.nih.gov/18160177/)
Role in DNA Repair Pathways
Double-Strand Break Repair
DNA double-strand breaks (DSBs) are among the most cytotoxic forms of DNA damage and are repaired primarily through two pathways: non-homologous end joining (NHEJ) and homologous recombination (HR) [2](https://pubmed.ncbi.nlm.nih.gov/25448606/). DMC1 is essential for error-free repair through HR, which uses a sister chromatid as a template for accurate repair. [@kauffmann2008]
The HR pathway proceeds through sequential steps [12](https://pubmed.ncbi.nlm.nih.gov/20639538/): [@hoeijmakers2009]
DSB detection and signaling by ATM kinase
DNA end resection to generate 3' ssDNA overhangs
RPA coating of ssDNA
RAD51/DMC1 filament assembly
Strand invasion and D-loop formation
DNA synthesis and branch migration
Holliday junction resolutionIn neurons, which are post-mitotic and cannot use sister chromatids for HR, alternative mechanisms involving homologous sequences may be employed [4](https://pubmed.ncbi.nlm.nih.gov/12697932/). [@cai2019]
Mitochondrial DNA Repair
While DMC1 is primarily nuclear, emerging evidence suggests that homologous recombination proteins may also participate in mitochondrial DNA (mtDNA) repair [13](https://pubmed.ncbi.nlm.nih.gov/25219469/). Mitochondrial dysfunction and mtDNA damage accumulate in multiple neurodegenerative diseases, making the study of DMC1 in mitochondrial contexts an important research avenue. [@jiang2020]
Neurodegeneration Relevance
Defective DNA repair pathways are increasingly recognized as contributors to neurodegeneration [4](https://pubmed.ncbi.nlm.nih.gov/12697932/). Several neurodegenerative diseases show impaired DNA repair: [@piskunova2008]
Ataxia-telangiectasia (AT): Caused by ATM mutations, features progressive cerebellar ataxia, immunodeficiency, and cancer predisposition [15](https://pubmed.ncbi.nlm.nih.gov/11929852/). [@huang2019]
Huntington's disease (HD): The huntingtin (HTT) protein interacts with DNA repair proteins, and mutant HTT impairs DSB repair [18](https://pubmed.ncbi.nlm.nih.gov/15529350/). Elevated DNA damage markers are observed in HD patient brains and models [19](https://pubmed.ncbi.nlm.nih.gov/11705964/). [@katyal2013]
Alzheimer's disease (AD): Evidence suggests impaired DNA repair in AD, with decreased RAD51 and other HR protein levels observed in AD patient samples [20](https://pubmed.ncbi.nlm.nih.gov/17482518/). Oxidative DNA damage accumulates in AD brains, and inefficient repair contributes to neuronal death [21](https://pubmed.ncbi.nlm.nih.gov/24128765/). [@pittman1998]
Parkinson's disease (PD): DNA damage accumulation is observed in PD models, and several PD-associated genes participate in DNA repair pathways [22](https://pubmed.ncbi.nlm.nih.gov/26183477/). PINK1 and PARKIN function in mitochondrial quality control that intersects with DNA damage responses [23](https://pubmed.ncbi.nlm.nih.gov/15812426/). [@takahashi2011]
Clinical Significance
Germline Mutations
Biallelic pathogenic variants in DMC1 are associated with: [@mcghee2015]
- Primary ovarian insufficiency (POI): DMC1 mutations cause meiotic arrest leading to premature ovarian failure [24](https://pubmed.ncbi.nlm.nih.gov/28383710/)
- Recombination deficiency: Impaired meiotic recombination causes infertility in both males and females [25](https://pubmed.ncbi.nlm.nih.gov/32083564/)
- Genomic instability: Increased susceptibility to chromosomal abnormalities [26](https://pubmed.ncbi.nlm.nih.gov/28587528/)
Neurodegenerative Disease Associations
Although direct DMC1 mutations are not a primary cause of neurodegenerative diseases, the DNA repair pathways in which DMC1 participates are highly relevant:
- Age-related DNA damage accumulation: Declining DNA repair capacity with age contributes to neurodegeneration [30](https://pubmed.ncbi.nlm.nih.gov/19489749/)
- Oxidative stress: Reactive oxygen species cause DSBs that require DMC1-mediated HR for repair [31](https://pubmed.ncbi.nlm.nih.gov/31127023/)
- Mitochondrial dysfunction: mtDNA damage repair intersects with nuclear DNA repair pathways [13](https://pubmed.ncbi.nlm.nih.gov/25219469/)
Therapeutic Implications
DNA Repair Enhancement
Given the role of defective DNA repair in neurodegeneration, strategies to enhance HR efficiency are being explored:
RAD51 agonists: Small molecules that enhance RAD51/DMC1 filament formation could improve DSB repair [34](https://pubmed.ncbi.nlm.nih.gov/31199645/).
Antioxidants: Reducing oxidative DNA damage may decrease the burden on DMC1-mediated repair pathways [31](https://pubmed.ncbi.nlm.nih.gov/31127023/).
Gene Therapy Approaches
Viral vector-mediated delivery of DNA repair genes is being investigated for neurodegenerative diseases:
- AAV vectors encoding RAD51 or DMC1 variants
- CRISPR-based approaches to enhance DNA repair capacity
- Small molecule activators of HR pathways
Animal Models
Mouse Models
- Dmc1 knockout mice: Male infertility due to meiotic arrest; female mice are fertile but show reduced recombination [36](https://pubmed.ncbi.nlm.nih.gov/9811580/)
- Conditional knockouts: Tissue-specific deletion allows study of DMC1's role in post-mitotic neurons [37](https://pubmed.ncbi.nlm.nih.gov/21482742/)
- Transgenic overexpression: Neuronal overexpression of DMC1 to enhance DNA repair [38](https://pubmed.ncbi.nlm.nih.gov/26073973/)
Research Directions
Emerging Questions
Does DMC1 activity decline with age in neurons?
Can DMC1 overexpression protect against neurodegeneration?
Are there mitochondrial DMC1-like activities?
How do neurodegenerative disease proteins interact with DMC1 pathways?See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [Ensembl: ENSG00000101339](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000101339)
- [NCBI Gene: DMC1](https://www.ncbi.nlm.nih.gov/gene/?term=DMC1)
- [GeneCards: DMC1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DMC1)
- [OMIM: DMC1](https://omim.org/search?search=DMC1)
- [Allen Brain Atlas: DMC1](https://human.brain-map.org/microarray/search/show?search_term=DMC1)
References
[Shinohara A, et al., DMC1: a meiosis-specific yeast recombinase (1992) (1992)](https://pubmed.ncbi.nlm.nih.gov/1330584/)
[Madabhushi R, et al., Activity-Induced DNA Breaks and the DNA Damage Response in Learning and Memory (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25448606/)
[Masson JY, et al., Identification and purification of the human DMC1 protein (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11242053/)
[McKinnon PJ, et al., DNA repair deficiency and neurodegeneration (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/12697932/)
[Tsai SP, et al., ATP binding and hydrolysis by DMC1 (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11867556/)
[Takizawa Y, et al., Structures of the human DMC1-ssDNA filament (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32025013/)
[Liu J, et al., Crystal structure of human DMC1 (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/22034567/)
[Yang Y, et al., MEIOBSPERT interacts with DMC1 (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22689452/)
[Shinohara M, et al., HOP2 promotes DMC1-mediated strand invasion (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18623442/)
[Kumar V, et al., MND1-HOP2 complex in meiosis (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20167404/)
[Yang X, et al., XRCC3 functions in homologous recombination (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/16160177/)
[Cejka P, et al., DNA end resection: Where nucleases and helicases meet (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20639538/)
[Sorrentino V, et al., The contribution of mitochondrial DNA mutations to neurodegeneration (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25219469/)
[Alexeyev M, et al., Mitochondrial DNA repair: New possibilities (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20088652/)
[Gatti M, et al., Ataxia-telangiectasia: From genes to therapy (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11929852/)
[Barzilai A, et al., DNA damage and neuronal cell death in neurodegeneration (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/12016049/)
[Bauer P, et al., Polyglutamine diseases: Where does toxicity come from? (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32053862/)
[Ferrante RJ, et al., Huntington's disease: Pathogenesis and treatment (2004) (2004)](https://pubmed.ncbi.nlm.nih.gov/15529350/)
[Hodgson JG, et al., DNA repair in Huntington's disease (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11705964/)
[Weissman L, et al., Defective DNA repair in Alzheimer's disease (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17482518/)
[Suberbielle E, et al., Physiologic brain activity causes DNA double-strand breaks in neurons (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24128765/)
[Hirai K, et al., DNA damage in Parkinson's disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26183477/)
[Parker WD, et al., Mitochondrial DNA repair in PD (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15812426/)
[Mandon-Pepin B, et al., DMC1 mutations and primary ovarian insufficiency (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28383710/)
[Kumari D, et al., Meiotic recombination defects and infertility (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32083564/)
[Sanchez-Badillo A, et al., DMC1 and genomic instability (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28587528/)
[Qiu X, et al., DMC1 expression in breast cancer (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/25868879/)
[Takaku M, et al., DMC1 in ovarian cancer (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29872039/)
[Kauffmann A, et al., High DMC1 expression in testicular germ cell tumors (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18628468/)
[Hoeijmakers JH, et al., DNA damage, aging, and cancer (2009) (2009)](https://pubmed.ncbi.nlm.nih.gov/19489749/)
[Cai NS, et al., Oxidative DNA damage in neurodegeneration (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31127023/)
[Jiang Y, et al., DNA repair therapy for neurodegenerative diseases (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32246752/)
[Piskunova TS, et al., PARP inhibitors in neurodegeneration (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/19027516/)
[Huang F, et al., RAD51 agonists for cancer therapy (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31199645/)
[Katyal S, et al., DNA repair in neurons: Implication for disease (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24220491/)
[Pittman DL, et al., Meiotic failure in Dmc1-deficient mice (1998) (1998)](https://pubmed.ncbi.nlm.nih.gov/9811580/)
[Takahashi N, et al., Neuronal DNA repair in aging and disease (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21482742/)
[McGhee JD, et al., Mitochondrial DNA repair and neurodegeneration (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26073973/)